Diospyros blancoi attenuates asthmatic effects in a mouse model of airway inflammation

Inflammation

Volumn 35, Issue 2, 2012, Pages 623-632

  Lee, Kyoung Youl ^a   Jung, Ju Young ^b   Lee, Mee Young ^c   Jung, Dayoung ^b   Cho, Eun Sang ^b   Son, Hwa Young ^b  

^a Kongju National University   (South Korea)

^b Chungnam National University   (South Korea)

^c Korea Institute of Oriental Medicine (KIOM)   (South Korea)

Author keywords

Asthma; Cytokine; Eosinophilia; Inflammation

Indexed keywords

ANTIASTHMATIC AGENT; DEXAMETHASONE; DIOSPYROS BLANCOI EXTRACT; EOTAXIN; GELATINASE B; HEME OXYGENASE 1; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G1; INTERLEUKIN 4; INTERLEUKIN 5; METHANOL; OVALBUMIN; PLANT EXTRACT; UNCLASSIFIED DRUG;

ALLERGIC ASTHMA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; DIOSPYROS; DIOSPYROS BLANCOI; DRUG DOSE COMPARISON; DRUG EFFICACY; ENZYME INHIBITION; EOSINOPHIL; FEMALE; GOBLET CELL; HISTOPATHOLOGY; IMMUNOGLOBULIN BLOOD LEVEL; INFLAMMATORY CELL; LUNG LAVAGE; LUNG PARENCHYMA; LYMPHOCYTE; MACROPHAGE; MOUSE; MUCUS SECRETION; NONHUMAN; PLANT LEAF; PROTECTION; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RESPIRATORY TRACT INFLAMMATION; SENSITIZATION;

ANIMALS; ANTI-ASTHMATIC AGENTS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASTHMA; BRONCHOALVEOLAR LAVAGE FLUID; DIOSPYROS; DISEASE MODELS, ANIMAL; EOSINOPHILS; FEMALE; HEME OXYGENASE-1; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; INTERLEUKIN-4; INTERLEUKIN-5; LUNG; LYMPHOCYTES; MACROPHAGES; MATRIX METALLOPROTEINASE 9; MICE; MICE, INBRED BALB C; OVALBUMIN; PHYTOTHERAPY; PLANT EXTRACTS;

DIOSPYROS BLANCOI; MURINAE; MUS;

EID: 84863780027     PISSN: 03603997     EISSN: 15732576     Source Type: Journal    
DOI: 10.1007/s10753-011-9354-0     Document Type: Article

References (46)

1. Lee, Y.S., O.K. Han, C.W. Park, C.H. Yang, T.W. Jeon, W.K. Yoo, S. H. Kim, and H.J. Kim. 2005. Pro-inflammatory cytokine gene expression and nitric oxide regulation of aqueous extracted Astragali radix in RAW 264.7 macrophage cells. Journal of Ethnopharmacology 100: 289-294. (Pubitemid 41206623)
2. Elias, J.A., C.G. Lee, T. Zheng, B. Ma, R.J. Homer, and Z. Zhu. 2003. New insights into the pathogenesis of asthma. The Journal of Clinical Investigation 111: 291-297. (Pubitemid 36182201)
3. Kay, A.B. 2001. Allergy and allergic diseases, first of two parts. The New England Journal of Medicine 344: 30-37. (Pubitemid 32064843)
4. Choi, A.M., and J. Alam. 1996. Heme oxygenase-1: Function, regulation, and implication of a novel stress-inducible protein in oxidant-induced lung injury. American Journal of Respiratory Cell and Molecular Biology 15: 9-19. (Pubitemid 126439851)
5. Barnes, P.J. 1990. Reactive oxygen species and airway inflammation. Free Radical Biology & Medicine 9: 235-243.
6. Kharitonov, S.A., K.F. Chung, D. Evans, B.J. O'Connor, and P.J. Barnes. 1996. Increased exhaled nitric oxide in asthma is mainly derived from the lower respiratory tract. American Journal of Respiratory and Critical Care Medicine 153: 1773-1780. (Pubitemid 26187898)
7. Goetzl, E.J., M.J. Banda, and D. Leppert. 1996. Matrix metalloproteinases in immunity. Journal of Immunology 156: 1-4. (Pubitemid 26006939)
8. Kelly, E.A., W.W. Busse, and N.N. Jarjour. 2000. Increased matrix metalloproteinase-9 in the airway after allergen challenge. American Journal of Respiratory and Critical Care Medicine 162: 1157-1161.
9. Kheradmand, F., K. Rishi, and Z. Werb. 2002. Signaling through the EGF receptor controls lung morphogenesis in part by regulating MT1-MMP-mediated activation of gelatinase A/MMP2. Journal of Cell Science 115: 839-848. (Pubitemid 34196343)
10. Mautino, G., N. Oliver, P. Chanez, J. Bousquet, and F. Capony. 1997. Increased release of matrix metalloproteinase-9 in bronchoalveolar lavage fluid and by alveolar macrophages of asthmatics. American Journal of Respiratory Cell and Molecular Biology 17: 583-591. (Pubitemid 127499061)
11. Parks, W.C., and S.D. Shapiro. 2001. Matrix metalloproteinases in lung biology. Respiratory Research 2: 10-19. (Pubitemid 34187902)
12. Pardo, A., R. Barrios, V. Maldonado, J. Melendez, J. Perez, V. Ruiz, L. Sequra-Valdez, J.I. Sznaider, and M. Selman. 1998. Gelatinases A and B are up-regulated in rat lungs by subacute hyperoxia: Pathogenetic implications. American Journal of Pathology 153: 833-844. (Pubitemid 28419036)
13. Perez-Ramos, J., M.D. Segura-Valdez, B. Vanda, M. Selman, and A. Pardo. 1999. Matrix metalloproteinases 2, 9, and 13, and tissue inhibitors of metalloproteinases 1 and 2 in experimental lung silicosis. American Journal of Respiratory and Critical Care Medicine 160: 1274-1282. (Pubitemid 29487471)
14. Tan, R.J., C.L. Fattman, L.M. Niehouse, J.M. Tobolewski, L.E. Hanford, Q. Li, F.A. Monzon, W.C. Parks, and T.D. Oury. 2006. Matrix metalloproteinases promoted inflammation and fibrosis in asbestosis-induced lung injury in mice. American Journal of Respiratory Cell and Molecular Biology 35: 289-297. (Pubitemid 44353396)
15. Okada, S., H. Kita, T.J. George, G.J. Gleich, and K.M. Leiferman. 1997. Migration of eosinophils through basement membrane components in vitro: Role of matrix metalloproteinase-9. American Journal of Respiratory Cell and Molecular Biology 17: 519-528. (Pubitemid 127500985)
16. Leppert, D., E. Waubant, R. Galardy, N.W. Bunnett, and S.L. Hauser. 1995. T cell gelatinases mediate basement membrane transmigration in vitro. Journal of Immunology 154: 4379-4389.
17. Delclaux, C., C. Delacourt, M.P. D'Ortho, V. Boyer, C. Lafuma, and A. Harf. 1996. Role of gelatinase B and elastase in human polymorphonuclear neutrophil migration across basement membrane. American Journal of Respiratory Cell and Molecular Biology 14: 288-295. (Pubitemid 126439823)
18. Cataldo, D., C. Munaut, A. Noel, F. Frankenne, P. Bartsch, J.M. Foidart, and R. Louis. 2000. MMP-2-and MMP-9-linked gelatinolytic activity in the sputum from patients with asthma and chronic obstructive pulmonary disease. International Archives of Allergy and Immunology 123: 259-267.
19. Fukuda, Y., M. Ishizaki, S. Kudoh, M. Kitaichi, and N. Yamanaka. 1998. Localization of matrix metalloproteinases-1, -2, and -9 and tissue inhibitor of metalloproteinase-2 in interstitial lung diseases. Laboratory Investigation 78: 687-698. (Pubitemid 28307326)
20. Russell, R.E., S.V. Culpitt, C. DeMatos, L. Donnelly, M. Smith, J. Wiggins, and P.J. Barnes. 2002. Release and activity of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 by alveolar macrophages from patients with chronic obstructive pulmonary disease. American Journal of Respiratory Cell and Molecular Biology 26: 602-609. (Pubitemid 34315869)
21. Lanchou, J., M. Corbel, M. Tanguy, N. Germain, E. Boichot, N. Theret, B. Clement, V. Laqente, and Y. Malledant. 2003. Imbalance between matrix metalloproteinases (MMP-9 and MMP-2) and tissue inhibitors of metalloproteinases (TIMP-1 and TIMP-2) in acute respiratory distress syndrome patients. Critical Care Medicine 31: 536-542. (Pubitemid 36232952)
22. Lee, Y.C., C.H. Song, H.B. Lee, J.L. Oh, Y.K. Rhee, H.S. Park, and G.Y. Koh. 2001. A murine model of toluene diisocyanate-induced asthma can be treated with matrix metalloproteinase inhibitor. The Journal of Allergy and Clinical Immunology 108: 1021-1026. (Pubitemid 33151557)
23. Stuart, G. 2009. An illustrated compilation of Philippine medicinal plants. http://www.stuartxchange.com/Mabolo.html. Accessed 6 Apr 2009
24. Lee, M.Y., C.S. Seo, J.A. Lee, N.H. Lee, J.H. Kim, H. Ha, M.S. Zheng, J.K. Son, and H.K. Shin. 2011. Anti-asthmatic effects of Angelica dahurica against ovalbumin-induced airway inflammation via upregulation of heme oxygenase-1. Food and Chemical Toxicology 49: 829-37.
25. Heussen, C., and E.B. Dowdle. 1980. Electrophoretic analysis of plasminogen activators in polyacrylamide gels containing sodium dodecyl sulfate and copolymerized substrates. Analytical Biochemistry 102: 196-202. (Pubitemid 10099499)
26. Papi, G.I.M., A. Caramori, and P.J. Barnes. 2009. Rescue treatment in asthma. More than as-needed bronchodilation. Chest 135: 1628-1633.
27. Barnes, P.J., and I.M. Adcock. 2009. Glucocorticoid resistance in inflammatory diseases. Lancet 373: 1905-1917.
28. Ohkawara, Y., X.F. Lei, M.R. Stampfli, J.S. Marshall, Z. Xing, and M. Jordana. 1997. Cytokine and eosinophil responses in the lung, peripheral blood, and bone marrow compartments in a murine model of allergen-induced airways inflammation. American Journal of Respiratory Cell and Molecular Biology 16: 510-520. (Pubitemid 127498283)
29. Wegmann, M., H. Fehrenbach, A. Fehrenbach, T. Held, C. Schramm, H. Garn, and H. Renz. 2005. Involvement of distal airways in a chronic model of experimental asthma. Clinical and Experimental Allergy 35: 1263-1271.
30. Yamaoka, K.A., B. Dugas, N. Paul-Eugene, J.M. Mencia-Huerta, P. Braquet, and J.P. Kolb. 1994. Leukotriene B4 enhances IL-4-induced IgE production from normal human lymphocytes. Cellular Immunology 156: 124-134.
31. Robinson, D., Q. Hamid, A. Bentley, S. Ying, A.B. Kay, and S.R. Durham. 1993. Activation of CD4+T cells, increased TH2-type cytokine mRNA expression, and eosinophil recruitment in bronchoalveolar lavage after allergen inhalation challenge in patients with atopic asthma. The Journal of Allergy and Clinical Immunology 92: 313-24. (Pubitemid 23254120)
32. Palframan, R.T., P.D. Collins, T.J. Williams, and S.M. Rankin. 1998. Eotaxin induces a rapid release of eosinophils and their progenitors from the bone marrow. Blood 91: 2240-8. (Pubitemid 28155496)
33. Monteseirín, J. 2009. Neutrophils and asthma. Journal of Investigational Allergology and Clinical Immunology 19: 340-54.
34. Wark, P.A., and P.G. Gibson. 2003. Clinical usefulness of inflammatory markers in asthma. American Journal of Respiratory Medicine 2: 11-19. (Pubitemid 37062713)
35. Bochner, B.S., and W.W. Busse. 2004. Advances in mechanisms of allergy. The Journal of Allergy and Clinical Immunology 113: 868-875. (Pubitemid 38608595)
36. Wegmann, M. 2009. Th2 cells as targets for therapeutic intervention in allergic bronchial asthma. Expert Review of Molecular Diagnostics 9: 85-100.
37. Bowen, H., A. Kelly, T. Lee, and P. Lavender. 2008. Control of cytokine gene transcription in Th1 and Th2 cells. Clinical and Experimental Allergy 38: 1422-1431.
38. Larche, M., D.S. Robinson, and A.B. Kay. 2003. The role of T lymphocytes in the pathogenesis of asthma. The Journal of Allergy and Clinical Immunology 111: 450-464.
39. Wang, Y., and C.T. McCusker. 2005. Interleukin-13-dependent bronchial hyper-responsiveness following isolated upper-airway allergen challenge in a murine model of allergic rhinitis and asthma. Clinical and Experimental Allergy 35: 1104-1111. (Pubitemid 41603146)
40. Chapman, J.T., L.E. Otterbein, J.A. Elias, and A.M. Choi. 2001. Carbon monoxide attenuates aeroallergen-induced inflammation in mice. American Journal of Physiology. Lung Cellular and Molecular Physiology 281: 209-L216.
41. Otterbein, L.E., F.H. Bach, J. Alam, M. Soares, H. Tao Lu, M. Wysk, R.J. Davis, R.A. Flavell, and A.M. Choi. 2000. Carbon monoxide has anti-inflammatory effects involving the mitogen-activated protein kinase pathway. Nature Medicine 6: 422-428. (Pubitemid 30208159)
42. van Scott, M.R., J.P. Justice, J.F. Bradfield, E. Enright, A. Sigounas, and S. Sur. 2000. IL-10 reduces Th2 cytokine production and eosinophilia but augments airway reactivity in allergic mice. American Journal of Physiology 278: 667-674.
43. Vogt, B.A., J. Alam, A.J. Croatt, G.B. Vercellotti, and K.A. Nath. 1995. Acquired resistance to acute oxidative stress. Possible role of heme oxygenase and ferritin. Laboratory Investigation 72: 474-483.
44. Ameredes, B.T., L.E. Otterbein, L.K. Kohut, A.L. Gligonic, W.J. Calhoun, and A.M. Choi. 2003. Low-dose carbon monoxide reduces airway hyperresponsiveness in mice. American Journal of Physiology. Lung Cellular and Molecular Physiology 285: 1270-1286.
45. Keshavan, P., T.L. Deem, S.J. Schwemberger, G.F. Babcock, J.M. Cook-Mills, and S.D. Zucker. 2005. Unconjugated bilirubin inhibits VCAM-1-mediated transendothelial leukocyte migration. Journal of Immunology 174: 3709-3718. (Pubitemid 40354082)
46. Lee, K.S., S.M. Jin, H.J. Kim, and Y.C. Lee. 2003. Matrix metalloproteinase inhibitor regulates inflammatory cell migration by reducing ICAM-1 and VCAM-1 expression in a murine model of toluene diisocyanate-induced asthma. The Journal of Allergy and Clinical Immunology 111: 1278-1284. (Pubitemid 36683683)